Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666782 · ClinicalTrials.gov registry record · Phase 2
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy
A Phase 2 study of Cancer and Influenza Viral Infections, sponsored by Saad Jamshed MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
- 2
- Study locations
NCT01666782 is a Phase 2 study of Cancer and Influenza Viral Infections that has completed, run by Saad Jamshed MD. The registered enrollment target is 105 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01666782, a Phase 2 study of Cancer and Influenza Viral Infections, has completed, sponsored by Saad Jamshed MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
- 2
- Study locations
Study Summary
The safety and immunogenicity of high dose influenza vaccine has not been studied in young patients receiving chemotherapy. This study will evaluate and compare the immunogenicity and safety of high dose influenza to standard dose influenza vaccine in adult oncology patients who are younger than 65 years old receiving chemotherapy.
Conditions Studied
Interventions
- BIOLOGICAL Standard Trivalent Influenza Vaccine
- BIOLOGICAL High-Dose Influenza Vaccine
Study Locations (2)
New York
- Rochester General Hospital - Rochester
- Lipson Cancer Center Linden Oaks Medical Campus - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01666782
The ClinicalTrials.gov registry entry for NCT01666782 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Saad Jamshed MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard Trivalent Influenza Vaccine is the first listed.
NCT01666782 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01666782 about?
NCT01666782 is a clinical study titled "Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy". The safety and immunogenicity of high dose influenza vaccine has not been studied in young patients receiving chemotherapy. This study will evaluate and compare the immunogenicity and safety of high dose influenza to standard dose influenza vaccine in adult oncology patients who are younger than 65 ...
What is the current status of trial NCT01666782?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2012-08. Estimated completion is 2015-12.
What conditions does trial NCT01666782 study?
This clinical trial studies the following conditions: Cancer, Influenza Viral Infections.
What interventions are being tested in trial NCT01666782?
The interventions under investigation include: Standard Trivalent Influenza Vaccine (BIOLOGICAL), High-Dose Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01666782?
This trial is sponsored by Saad Jamshed MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01666782 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
RECRUITING · Phase 2
-
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
RECRUITING · Phase 2
-
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.